Antonio Herce
InvestorAssociate at Inveready Technology Investment Group
Barcelona, Spain
Writes $300K – $1.8M checks · typically $875K
About
Investment Director who joined Inveready in 2019 and has taken part in investments across more than 20 companies plus several divestments, handling deal analysis, due diligence coordination, and portfolio management. He sits on the boards of Nanoligent, Atlas Molecular Pharma, Galgo Medical, and StereoDive, and previously worked in technology transfer and business development. He holds a Biotechnology degree and an MSc in Management of Biomedical Companies from the University of Barcelona.
Invests in
BiotechMedical Devices
Investments
Board seats
Atlas Molecular PharmaGalgo MedicalNanoligentStereoDive
Per the firm's website.
Colleagues at Inveready Technology Investment Group
Network6
Investors connected to Antonio in public investor directories — a warm-intro map.